SMA Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
SMA is not a good buy right now for an impatient investor. The chart trend is clearly bearish (stacked bearish moving averages and a weakening MACD), and there are no Intellectia buy signals to override that. While options positioning (very low put/call open interest ratio) looks bullish, there’s essentially no options volume confirming near-term conviction. With profitability metrics deteriorating sharply in the latest reported quarter and earnings approaching on 2026-02-04, the better decision right now is to HOLD/avoid new buys until price shows a decisive reversal back above the pivot (~32.28) and momentum stabilizes.
Trend is bearish. Moving averages are stacked negatively (SMA_200 > SMA_20 > SMA_5), indicating persistent downside pressure across long-, mid-, and short-term timeframes. MACD histogram is -0.121 and negatively expanding, confirming weakening momentum. RSI(6) at ~32.6 is near oversold territory, which can allow for short bounces, but it is not a confirmed reversal signal by itself. Key levels: immediate support S1 ~31.19 (price 31.33 is hovering just above it); next support S2 ~30.52. Resistance starts at the pivot ~32.28, then R1 ~33.36.
Intellectia Proprietary Trading Signals
Pattern-based forward look provided: ~50% chance of only +0.13% next day, but -0.36% next week and -1.29% next month—consistent with a weak near-term tape.
Potential technical bounce setup: RSI near oversold and price sitting just above S1 (~31.
can produce a reflex rally if support holds.
Wall Street upside still exists in targets from the bullish analysts: recent targets of $35 (Scotiabank Outperform, JPMorgan price target maintained despite downgrade) and $38 (Truist Buy) imply upside from 31.33 if fundamentals stabilize.
Earnings on 2026-02-04 (after hours) could act as a catalyst if guidance, occupancy, pricing power, or churn mitigation shows improvement.
Clear bearish trend and weakening momentum: bearish MA stack + MACD negative and expanding increases the odds of further downside before any durable reversal.
Profitability deterioration in the latest quarter (net income, EPS, and gross margin all down materially YoY) raises questions about earnings quality and operating leverage.
Analyst sentiment has become more mixed: JPMorgan downgraded to Underweight, and even the bullish analysts trimmed targets—suggesting limited near-term multiple expansion.
No recent news flow to change the narrative, and no notable hedge fund/insider trend signal provided (both neutral).
Latest reported quarter: 2025/Q3. Revenue grew to $70.43M (+17.08% YoY), which is the main positive (top-line expansion). However, profitability sharply weakened: net income fell to $5.06M (-179.84% YoY) and EPS dropped to $0.09 (-228.57% YoY). Gross margin declined to 58.45% (-11.60% YoY). Net takeaway: growth is present, but margins/earnings trend is moving in the wrong direction, which typically caps near-term upside unless the next earnings update shows a reversal.
Recent trend: price targets have been cut modestly (Scotiabank $36→$35; Truist $39→$38), and JPMorgan downgraded the stock to Underweight (from Neutral) while keeping a $35 target. Wall Street pros: multiple firms still see upside and highlight SmartStop’s ability to offset churn via customer rate increases (Scotiabank Outperform; Truist Buy). Wall Street cons: sector view is not particularly cheap and self-storage is more neutral within REIT preferences (Truist), and JPMorgan’s Underweight signals a more cautious stance on relative performance. Overall: constructive-but-cautious, with the most notable change being the JPMorgan downgrade.
Politicians / influential figures: No recent congress trading data available, and no politician trading signal is indicated.
